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Abstract
Background: Carbon black nanoparticles (CBNP) are mainly composed of carbon, with a small amount of other
elements (including hydrogen and oxygen). The toxicity of CBNP has been attributed to their large surface area,
and through adsorbing intrinsically toxic substances, such as polycyclic aromatic hydrocarbons (PAH). It is not clear
whether a PAH surface coating changes the toxicological properties of CBNP by influencing their physicochemical
properties, through the specific toxicity of the surface-bound PAH, or by a combination of both.
Methods: Printex®90 (P90) was used as CBNP; the comparators were P90 coated with either benzo[a]pyrene (BaP)
or 9-nitroanthracene (9NA), and soot from acetylene combustion that bears various PAHs on the surface (AS-PAH).
Oxidative stress and IL-8/KC mRNA expression were determined in A549 and bronchial epithelial cells (16HBE14o-,
Calu-3), mouse intrapulmonary airways and tracheal epithelial cells. Overall toxicity was tested in a rat inhalation
study according to Organization for Economic Co-operation and Development (OECD) criteria. Effects on cytochrome
monooxygenase (Cyp) mRNA expression, cell viability and mucociliary clearance were determined in acute exposure
models using explanted murine trachea.
Results: All particles had similar primary particle size, shape, hydrodynamic diameter and ζ-potential. All PAH-containing
particles had a comparable specific surface area that was approximately one third that of P90. AS-PAH contained a
mixture of PAH with expected higher toxicity than BaP or 9NA. PAH-coating reduced some effects of P90 such as IL-8
mRNA expression and oxidative stress in A549 cells, granulocyte influx in the in vivo OECD experiment, and
agglomeration of P90 and mucus release in the murine trachea ex vivo. Furthermore, P90-BaP decreased particle transport
speed compared to P90 at 10 μg/ml. In contrast, PAH-coating induced IL-8 mRNA expression in bronchial epithelial cell
lines, and Cyp mRNA expression and apoptosis in tracheal epithelial cells. In line with the higher toxicity compared to P90-
BaP and P90-9NA, AS-PAH had the strongest biological effects both ex vivo and in vivo.
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Conclusions: Our results demonstrate that the biological effect of CBNP is determined by a combination of specific surface
area and surface-bound PAH, and varies in different target cells.
Keywords: Carbon black nanoparticles, Polycyclic aromatic hydrocarbons, Airway epithelial cells, Physicochemical
characteristics, Mucociliary clearance, Cytotoxicity
Background
The toxicity of nanoparticles is thought to be deter-
mined by their surface reactivity, influenced in turn by
their chemical composition, physical properties and
surface chemistry [1–8]. Carbon black nanoparticles
(CBNP) are composed mainly of carbon with a small
amount of other elements (including hydrogen and oxy-
gen), and in themselves are nontoxic. However, CBNP
are potentially harmful since their large surface area can
interact with biological systems [1, 9–14]. Furthermore,
substances such as polycyclic aromatic hydrocarbons
(PAHs) that are intrinsically toxic can be adsorbed dur-
ing CBNP synthesis [15]. The theory that the toxicity of
CBNP can be increased by other substances has been
validated by the application of metal ions, which in-
creased the toxicity due to autophagy and lysosomal dys-
function [16]. However, it is still not clear how direct
binding of chemical add-ons to CBNP modifies their
interaction with biological systems [5, 17–19]. Several
outcomes are theoretically possible. First, binding of che-
micals to the particle surface can modify the surface
properties of CBNP, reducing the surface area, thereby
potentially reducing toxicological effects [1]. Second, the
toxicity of the bound substances can determine the over-
all toxicity of the resulting particles [20]. Third, the
modification could lead to a new particle type, whose
biological activity might be a combination of changed
physicochemical properties and the toxicity of the bound
substances.
A common surface modification of CBNP is the adsorp-
tion of PAHs, occurring during incomplete combustion
[21]. PAHs are thought to be mutagenic and carcinogenic,
generally after toxification by cytochrome P450 enzymes
(Cyp), and therefore are regarded as lung tumor inducing
substances, although with only very limited acute toxicity
[15, 22, 23]. Despite this limited acute toxicity, their effect
on biological systems can be easily monitored by their
potential to induce specific Cyp enzymes.
Compared with unmodified CBNP, surface modification
of CBNP with PAHs has not shown increased tumor in-
duction either following long-term exposure [24] or in cell
lines in terms of cytokine release, induction of single and
double strand breaks, cell cycle arrest, or phosphorylation
of p53 or histone [25–27]. This suggests that PAHs have
limited toxic effects when bound to CBNP, supporting the
theory that they are not biologically available in this state
[28] and that surface modification has a minor effect on
the overall toxicity of CBNP.
However, diesel exhaust particles that contain PAHs
are associated with an increased risk of asthma, and
experiments involving exposure of a bronchial cell
line to ultrafine particles implied a role of PAH in
their toxic effects [29–31]. Furthermore, removal of
PAHs from these exhaust particles resulted in reduced
carcinogenic potential [24]. These data suggests that
the effect of PAHs on the behavior of CBNP in bio-
logical systems is more complex.
Since inhalation is the predominant route of exposure
to CBNP, we tested the toxicity of particles in different
test systems including cell cultures, ex vivo studies on
excised airways, and an in vivo inhalation study
conducted according to Organization for Economic Co--
operation and Development (OECD) criteria [32].
Initially, we tested the CBNP in high-throughput cell
culture systems that can predict the toxicity of particles,
and which therefore allowed us to preselect CBNP for in
vivo testing. We then analyzed the in vivo effects of the
selected CBNP in inhalation studies, and then finally
tested the CBNP in ex vivo airway preparations to deter-
mine their impact on ciliary beat frequency, particle
transport speed and mucus appearance. In every test
system we analyzed parameters that indicate CBNP-
induced oxidative stress and IL-8 response.
This allowed us to compare specific toxicological
effects in each system to gain a more comprehensive
insight into the cellular effects of the particles.
Methods
To understand how surface modification can change
the interaction of CBNP with biological systems we
used PAHs to modify the surface of a toxicologically
well-defined CBNP, Printex®90 (P90). This is charac-
terized by a high surface area and has been widely
used in toxicological studies, resulting in only minor
toxic effects [1, 33, 34].
For modification of the P90 surface, we used ben-
zo[a]pyrene (BaP) and 9-nitroanthracene (9NA). BaP
was chosen because of the well characterized toxicity
of its metabolites, which are known to induce ROS
and DNA adducts [23, 35–38]. BaP is known to in-
duce Cyp1A1 and 1B1, which then metabolize BaP to
toxic metabolites; this therefore allows monitoring of
Lindner et al. Particle and Fibre Toxicology  (2017) 14:8 Page 2 of 17
BaP activity and its biological effect [39, 40]. In con-
trast, 9NA is a PAH that occurs during combustion,
and is regarded as a low toxicity PAH, as predicted
by the Ames test and human cell mutagenicity assay
[41–43]. However, due to its nitro group other toxic
mechanisms can occur induced by intermediates
resulting from reduction of the nitro group [41]. As
coating of a particle does not necessarily represent
the situation found in nanoparticles that acquire PAH
during synthesis, we also generated CBNP by acetyl-
ene combustion [44]. The resulting acetylene soot
(AS) had a mixture of PAHs on the surface (AS-PAH). In
the suspensions we used, AS-PAH had a slightly larger
specific surface area, but similar aggregate size and ζ-po-
tential compared to PAH-coated P90, The physicochemi-
cal parameters of the different particles were evaluated by
a variety of analytic test methods (see Tables 1, 2 in the
Results section and Additional files 1, 2).
Particle synthesis and characterization
Modification of CBNP
80 g of unmodified P90 (Evonik Carbon Black GmbH,
Frankfurt, Germany) together with 20 g of BaP (Thermo
Fisher Scientific-Alfa Aesar, Heysham, Lancashire, UK)
or 9NA (Merck Schuchardt OHG, Hohenbrunn, Germany)
were suspended in 100 ml dimethyl ether and incubated in
an ultrasonic bath at room temperature for 15 min. After
subsequent vacuum desiccation, the coated P90 nano-
particles were stored at room temperature.
Gas phase synthesis of AS-PAH
A flat flame burner in a low pressure combustion cham-
ber with acetylene as the fuel was used for the synthesis
of AS-PAH. The experiments were carried out with a
carbon to oxygen ratio of 1.1 to 1. The laminar mass
flow of acetylene was set via mass flow controllers
(Brooks 5850E; Brooks Instruments, Hatfield, PA, USA)
on 88 ln/h with the oxygen mass flow adjusted to 80 ln/h.
Temperature and pressure were monitored by a
thermocouple and a pressure sensor, with the pres-
sure set to 70 mbar during synthesis. The AS-PAH
was collected for 60 min on a filter (Gore Membrane
Filter Bags) between the combustion chamber and the
rotary vane pump (TRIVAC D 65 B; Oerlikon Leybold
Vakuum, Cologne, Germany).
Particle size distribution
The particle size distributions were measured by scan-
ning electron microscopy (SEM; Leo 1530; LEO Electron
Microscopy Inc., Thornwood, NY, USA) and transmis-
sion electron microscopy (TEM; CM200 FEG/ST,
Philips, Amsterdam, Netherlands). The PAHs on the
particle surface had to be extracted with toluene prior to
electron microscopy, as otherwise they would be cracked
by the beam and the particles would grow. Remaining
CBNP were then suspended with acetone in an ultra-
sonic bath, and the suspension was applied thinly using
an ultrasonic nebulizer, either to a silicon wafer (for
SEM) or to a 400 mesh cooper grid (Ted Pella, Inc.,
Redding, CA, USA) (for TEM). The diameter of 200 par-
ticles of 5 images was determined with the program
ImageJ. A log normal curve was fitted on the particle
size distribution to get the average particle diameter.
Thermal analysis
The thermal release of coated PAHs from P90 and of
volatile substances from AS-PAH was investigated using
a thermogravimetric analyzer (DuPont 951; DuPont
Company, Wilmington, DE, USA) connected to a quad-
rupole mass spectrometer (QMG 420; Balzers AG, Bal-
zers, Liechtenstein) through a differentially pumped inlet
system. The transfer line between the thermobalance and
the mass spectrometer was heated up to 400 °C to prevent
condensation of the pyrolysis products. The experiments
were performed with sample sizes of 5–10 mg at a heating
rate of 10 °C/min up to a final temperature of 800 °C at a
helium flow rate of 100 ml/min. Each sample was mea-
sured at least three times.
Identification of PAHs on AS-PAH surface
To characterize the PAHs on the particle surfaces,
CBNP samples were heated under dynamic conditions.
A sample of 100 mg was heated up in an oven in 10 °C/
min increments to vaporize the PAHs, with the volatile
PAHs collected in a cold trap. The condensed products
were dissolved in 5 ml toluene, and were characterized
by a standard gas chromatograph-mass spectrometer
(GC/MS-QP 2010SE; Shimadzu Corporation, Tokyo,
Japan). The chromatographic parameters for GC/MS
were: Phenomenex zb-5msi column (column length:
30 m; I.D.: 0.25 mm; film thickness 0.25 mm); injector
temperature 250 °C; oven temperature program: 65 °C at
5 min constant, 10 °C min to 350 °C at 10 min constant.
Specific surface area
The surface area was determined by Brunauer, Emmett
and Teller (BET) measurement using a BelSorp II device
(BelJapan, Inc., Osaka, Japan), using the BelSorp analysis
program.
Particle size and ζ-potential in suspension
Suspensions were prepared with 10 mg of sample plus
100 ml of double-deionized water. To keep the suspen-
sion stable, 500 mg of bovine serum albumin (BSA)
(AppliChemInc., Maryland Heights, MO, USA) was
added. The suspensions were treated with an ultrasonic
homogenizer (Sonoplus, Rod: VS 70 D; Bandelin elec-
tronic GmbH & Co. KG, Berlin, Germany) for 40 min in
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pulse mode, changing 20 times between 30 s ultrasonic
and 90 s resting interval. To avoid thermal denaturation
of BSA, the suspensions were cooled in a beaker con-
taining ice water during treatment. The particle size
measurements were carried out as soon as the
suspension had reached room temperature using a
Malvern ZetaSizer Nano-ZS (Malvern Instruments
Ltd, Worcestershire, UK). Particle size was quantified
by dynamic light scattering, and ζ-potential was mea-
sured by laser Doppler microelectrophoresis using the
Smoluchowski model. The index of refraction and the
absorption were preset at 2.0 in the measurement
software (DTS Nano; Malvern Instruments Ltd,
Worcestershire, UK). The cuvettes to measure the
particle size distribution and the ζ-potential were
washed using double-deionized water and ethanol
(70%) to remove potential impurities. Subsequently,
the cuvettes were rinsed using approximately 2 ml of
the sample, and were then filled with the sample and
placed in the Zetasizer Nano-ZS. The suspensions
were characterized in triplicates, and the means and
standard derivations were calculated.
Endotoxin tests
CBNP suspensions were tested for endotoxins using the
CROMO-LAL assay (Associates of Cape Cod Inc., East
Falmouth, MA, USA) according to the manufacturer’s
protocol. The limit of detection was 0.005 EU/ml (com-
parable to 0.5 pg/ml endotoxin of E. coli Type 055:B5).
The suspensions were only used for experiments if no
endotoxins were detected.
Experiments with human pulmonary cell lines
Cell culture
We used A549 cells (DSMZ, Braunschweig, Germany),
16HBE14o- cells (University California, San Francisco,
USA; described in [45]) and Calu-3 cells (American
Type Culture Collection, Manassas, VA, USA). The epi-
thelial cells were cultured in Dulbecco’s modified eagle’s
medium (DMEM) with 10% fetal calf serum (FCS) and
0.1% gentamicin for ROS and transepithelial electrical
resistance (TEER) measurements. For mRNA expression
analysis, A549 cells were cultured in DMEM (Fisher
Scientific GmbH, Schwerte, Germany) with 10% FCS
and 0.1% gentamicin, 16HBE14o- cells were cultured in
DMEM (Biochrom AG, Berlin, Germany) with 10% FCS
(PAA Laboratories GmbH, Cölbe, Germany) 1% L-glu-
tamine (Gibco™, Life Technologies GmbH, Darmstadt,
Germany) and 1% penicillin/streptomycin (Sigma Aldrich
Chemie GmbH, Taufkirchen, Germany), and Calu-3 cells
were cultured in RPMI 1640 containing stable glutamine
supplemented with 10% FCS, 100 U/ml penicillin and
100 μg/ml streptomycin (all from Biochrom AG, Berlin,
Germany). Cells were kept in a 37 °C humidified atmos-
phere containing 5% CO2.
Flow cytometric measurements of reactive oxygen
species (ROS)
Cells were seeded in T25 flasks (PAA Laboratories
GmbH, Cölbe, Germany), at 0.6 × 106 for A549 cells and
at 1 × 106 for 16HBE14o- cells. Subconfluent cultures
were exposed to CBNP at a concentration of 10 μg/ml
or 50 μg/ml for 24 h. The culture medium was subse-
quently removed and the cell monolayers were washed
twice with 5 ml pre-warmed phosphate buffered saline
(PBS). The fluorescent dye dichloro-dihydro-fluorescein
diacetate (DCFH-DA) was applied to the cells in 5 ml
fresh medium, with the resulting mixture incubated for
30 min at 37 °C. The culture medium was then removed
and the cells were washed twice with 5 ml pre-warmed
PBS and harvested by trypsinization. Flow cytometry
measurements were done with a FACScan cytometer
(Becton Dickinson Biosciences, San Jose, CA, USA)
equipped with a 488 nm argon laser, with CELLQuest™
software used for data acquisition. For each sample,
10,000 events were analyzed and fluorescence emission
of dichlorofluorescein (DCF) was examined at 530 nm.
Quantitative RT-PCR
A549 cells were seeded in T25 flasks at 0.6 × 106. Calu-3
cells and 16HBE14o- cells were seeded in 12-well plates
(Costar, Corning, NY, USA) at 5 × 105 cells and 1.6 × 105
cells, respectively. After reaching a confluency of ≥90%,
culture medium was exchanged and cells were treated
with CBNP at 10 μg/ml, 50 μg/ml or medium/BSA alone
for 24 h. Subsequently, cells were washed twice with
pre-warmed medium or PBS to remove particles, and
total RNA was extracted from Calu-3 cells using a
NucleoSpin RNA Kit (Macherey-Nagel, Düren, Germany)
and from A549 and 16HBE14o- cells using a RNeasy Kit
(Quiagen GmbH, Hilden, Germany) according to the
manufacturers’ instructions.
Reverse transcription was performed for RNA of A549
cells with the Omniscript Kit (Quiagen GmbH, Hilden,
Germany), of 16HBE14o- cells using MaximaFirstStrand
cDNA synthesis (Fermentas/Life Technologies GmbH,
Darmstadt, Germany), and of Calu-3 cells using
Oligo(dT)12–18 and Superscript III reverse transcriptase
(Thermo Fisher Scientific, Waltham, USA), all according
to the manufacturers’ protocols.
To quantify IL-8 and hypoxanthine-guanine phosphor-
ibosyltransferase (HPRT) mRNA levels in A549 cell
preparations, we used Viia™7 (Life Technologies GmbH,
Darmstadt, Germany); for preparations of 16HBE14o-
and Calu-3 cells, we used LightCycler 480 SYBR green I
Master (Roche Applied Science, Mannheim, Germany).
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The sequences of used IL-8 primers and housekeeping
gene HRPT1 primers are shown in Additional file 3. The
housekeeping gene was evaluated with GenEx software
(MultiD Analyses AB, Gothenburg, Sweden) [46]. The
quality of amplificates was tested by melting curve ana-
lysis. The n-fold change was calculated for A549 cells
with the program GenEx (GenEx Professional 5.4.3 Soft-
ware), and by normalization of relative expression data
to medium control data for 16HBE14o- and Calu-3 cells.
Measurement of the transepithelial electrical resistance
(TEER)
A total of 2 × 105 Calu-3 cells were seeded per well on
Transwell® filter inserts (polyester, 12-well plates, 12 mm
diameter, 0.4 μm pore size; Corning Costar, Bodenheim,
Germany) and cultivated for 9 days. On day 10, the cell
monolayers were exposed to CBNP at 10 μg/ml or
50 μg/ml for 24 h. The culture medium was changed
and the cells were incubated for at least 15 min at 37 °C,
before TEER was measured using an EVOM volt-ohm-
meter (World Precision Instruments, Sarasota, Fl, USA).
Statistical analysis
Differences between untreated controls and treated cul-
tures were considered statistically significant at p < 0.05.
Flow cytometric and TEER data were analyzed by two-
sided Student’s t-test for unpaired values using Microsoft
Excel. Relative mRNA expression results were analyzed
by Mann Whitney U test.
Nose-only inhalation study in rats
Animals
Male Wistar rats (strain Crl:WI (Han)) were purchased
from Charles River Deutschland (Sulzfeld, Germany).
The age of the animals was 10 to 11 weeks and the
weight 285 ± 24 g (mean ± SD) at the onset of exposure.
Rats were exposed to the test item by nose-only inhal-
ation. For 3 weeks prior to exposure, animals were
trained to become accustomed to nose-only tubes. The
OECD inhalation study on rats was approved by the
Niedersächsisches Landesamt für Verbraucherschutz und
Lebensmittelsicherheit (33.14 42502-04013/1199).
Study design and dosing scheme
The CBNP were administered to the test animals by
nose-only inhalation. P90, P90-BaP and AS-PAH were
tested; P90-9NA was not administered, given the previ-
ously described low toxicity [41–43] and the in vitro
tests in this study. A nominal aerosol concentration of
6 mg/m3 was used, with exposure of 6 h/day for two
weeks (no exposure on weekends) according to the
OECD criteria for acute exposure [32]. CBNP-related ef-
fects on innate immune cells in the bronchoalveolar lav-
age (BAL) and histopathological changes in lung tissue
were analyzed on day 1 and day 14 after cessation of ex-
posure. Potassium bromate (KBrO3) treated animals
(250 mg/kg in physiological saline, intraperitoneal)
served as positive controls for Comet-assay. The animals
were treated with KBrO3 on day 1 and day 14. BAL was
collected and analyzed 3 h after application.
Bronchoalveolar lavage and leukocyte determination
BAL was performed in five rats per group after the end
of exposure (day 1) and following a 14-day recovery
period. Following preparation, lungs were lavaged with
saline using two lavages of 5 ml each. The lavage fluid
was collected in calibrated tubes and the harvested vol-
ume was recorded. Leukocyte concentration was deter-
mined using a counting chamber, and two cytoslides
were prepared with a cytocentrifuge (Shandon Co.,
Frankfurt, Germany) for differential cell counts (macro-
phages, granulocytes, lymphocytes). The slides were air
dried, and the cells were stained with Diffquick solutions
(Medion Grifols Diagnostics AG, Düdingen, Switzerland)
and counted. The results are presented as percentage of
the total number of BAL cells.
Statistical analysis
Differences between BAL analysis groups were consid-
ered statistically significant at p < 0.05. Data were ana-
lyzed using analysis of variance. If the group means
differed significantly by the analysis of variance the
means of the treated groups were compared with the
means of the control groups using Dunnett’s test.
Experiments with explanted mouse trachea
Particle suspension in cell culture medium
For the ex vivo studies we used CBNP concentrations of
10 and 30 μg/ml. The concentration of 30 μg/ml was
calculated by surface correction of the in vitro
concentration.
The CBNP suspensions were diluted in DMEM (Gibco™,
Life Technologies GmbH, Darmstadt, Germany) with
20 mM HEPES, 1% penicillin/streptomycin (Sigma Aldrich
Chemie GmbH, Taufkirchen, Germany) and 2 mM L-glu-
tamine (Life Technologies GmbH, Darmstadt, Germany)
for incubation of tracheae.
Animals
We used 8 to 12 week old female Balb/c mice
(Charles River Laboratories, Sulzfeld, Germany). Mice
were euthanized with an overdose of isoflurane for
explantation of the trachea. The ex vivo studies on
mouse tracheae were approved by the Ministerium
für Landwirtschaft, Umwelt und ländliche Räume des
Landes Schleswig-Holstein.
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Preparation and culture conditions of explanted trachea
Tracheae were explanted and transferred to culture
dishes coated with a thin layer of Sylgard polymer and
filled with medium. Each trachea sample was fixed on
the bottom of a well with an insect needle, covered with
1 ml of medium with or without suspended CBNP and
incubated at 37 °C for 24 h.
Qualitative RT-PCR
To examine differences in mRNA expression levels, tra-
cheae were cut into two pieces. One piece was incubated
for 24 h with particle suspension; the other piece was in-
cubated in medium only, serving as negative control.
The epithelium was then removed using a sterile swab
(Collection Swab H268A; Copan diagnostic, Inc., Murrieta,
CA, USA). This isolation method was previously described
in [47]. The RNA was isolated with innuPREP RNA isola-
tion Kit (Analytic Jena AG, Jena, Germany) according to
the manufacturer’s protocols. Any remaining DNA was
enzymatically degraded using Amplification Grade DNase
I kit AMPD-1 (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany). The quality and quantity of isolated mRNA
was analyzed with a NanoDrop spectrophotometer
(Thermo Fisher Scientific, Waltham, MA, USA). The
mRNA was subsequently transcribed to cDNA using
RevertAid H Minus Reverse Transcriptase (Fisher
Scientific-Germany GmbH, Schwerte, Germany) mixed in
transcription buffer with dNTPs (0.6 mM) (Fisher
Scientific-Germany GmbH, Schwerte, Germany), DTT
(10 mM) (Life technologies GmbH, Darmstadt, Germany)
and random hexamer primers (17.5 ng/μl) (Biomers.net
GmbH, Ulm, Germany).
Real time RT-PCR was performed in TaqMan Universal
PCR Master Mix (Life technologies GmbH, Darmstadt,
Germany), with probes tagged with reporter 6-FAM and
quencher Tamra. The TaqMan probes and primers used
for quantitative real time RT-PCR are shown in
Additional file 3. The PCR program was: one cycle at
95 °C for 10 min followed by 50 cycles at 95 °C for 45 s
and at 60 °C for 1 min. Changes in the transcript levels
were determined by calculating the difference in cycle
threshold to the respective negative control with the ΔΔCt
method and represented as n-fold expression (2 −ΔΔCt).
Apoptosis and necrosis assays
Tracheae were explanted, incubated in pre-warmed
medium, opened and cut in four equal parts. One part
was cultured in medium alone, two parts were incubated
for 24 h with CBNP suspensions of 10 μg/ml and
30 μg/ml, respectively, and the remaining parts were
incubated for 24 h with 1 μM staurosporine (Roche
Diagnostics GmbH, Mannheim, Germany) or 1 mM
paraquat (Sigma-Aldrich GmbH, Seelze, Germany), re-
spectively as positive controls for the staining procedure.
For the apoptosis analysis, whole mount samples of tra-
cheae were fixed with phosphate buffered 4% paraformal-
dehyde (pH 7.4), followed by washing with PBS (pH 7.4)
and permeabilization with ice cold acetone. The speci-
mens were then incubated overnight at room temperature
with rabbit anti-cleaved caspase-3 antibody (#9661, dilu-
tion 1:300, Cell Signaling Technology Inc., Danvers, MA,
USA). The primary antibody was detected using
Alexa555-conjugated donkey anti-rabbit IgG (dilution
1:800, Life Technologies GmbH, Darmstadt, Germany).
For membrane damage analysis, ethidium homodimer-1
(1 μg/ml, Life Technologies GmbH, Darmstadt, Germany)
in medium was added to the trachea preparation, and was
then incubated for 30 min at 37 °C. The samples were
fixed with 4% paraformaldehyde (pH 7.4), washed with
PBS (pH 7.4) and permeabilized with acetone.
To identify the epithelial layer, ciliated cells were la-
beled with a mouse monoclonal antibody against acety-
lated α-tubulin (Clone 6-11B-1, Sigma-Aldrich GmbH,
Steinheim, Germany) that was directly labeled with
Atto488 (Lightning-Link™Atto488 conjugation kit; Innova
Bioscience Ltd., Cambridge, UK); cell nuclei were visual-
ized using Hoechst 33258 (0.1 μg/ml; Sigma-Aldrich,
Steinheim, Germany) (Additional file 4).
Apoptosis and cell membrane damage were analyzed
using a confocal laser scanning microscope (LSM 510
Meta; Carl Zeiss MicroImaging GmbH, Göttingen,
Germany) equipped with a Plan-Apochromat 20×/0.75
or C-Apochromat 40×/1.2 W objective. The total num-
ber of apoptotic and necrotic epithelial cells was counted
in the complete whole mount preparation.
Ciliary beat frequency and cilia-driven particle transport
Tracheae were transferred to a Delta T4 Culture dish
(Bioptechs Inc., Butler, PA, USA), the bottom of which
was covered with sylgard polymer. Samples were fixed
with insect needles with the epithelium facing upwards,
and were then covered with 2 ml of HEPES-Ringer solu-
tion. The temperature of HEPES-Ringer solution was
maintained at 30 °C using a Bioptechs Delta T4 Culture
Dish Controller (Bioptechs Inc., Butler, PA, USA), and
the epithelial surface was imaged using a Zeiss Axioskop
2 FS fixed stage microscope equipped with Achroplan
40×/0.80 W or 20×/0.50 W objectives (Carl Zeiss Micro-
Imaging GmbH, Göttingen, Germany).
Polystyrene particles (4.5 μm) were added to the
HEPES-Ringer solution with a concentration of 2 × 106
particles/ml. The transport of particles was recorded
with a SMX-150 M camera (EHD Imaging GmbH,
Damme, Germany). Movies (each with 200 images) of
polystyrene particle transport were recorded from at
least six different areas for each trachea at 12 Hz frame
rate and a resolution of 1280 × 1024 pixels. Particle
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transport speed was determined by tracking individual
particles and manually checking each recorded track
using Image-Pro® Plus 6.0 (Medium Cybernetics, Inc.,
Bethesda, MD, USA). The mean particle transport speed
was calculated for each experiment. Movies (each with
1000 images) of cilia motion were recorded at 100 Hz
frame rate and 640 × 480 pixels). The ciliary beat
frequency was determined by Fourier transformation of
grey level changes over time using an in-house devel-
oped software written in Mathlab (Mathworks, Natick,
MA, USA). For visualization of ciliary beat frequency,
the dominant frequency, i.e. the frequency with the
highest amplitude, was identified for every pixel in the
movie and color-coded. Movies were recorded from at
least six different areas for each trachea. The ciliary beat
frequency of a minimum of 10 ciliated cells was measured
in every movie and the mean frequency from these cells
was calculated. To increase ciliary beat frequency or
cilia-driven particle transport, ATP (10 μM) was applied
as positive control.
Statistical analysis
All ex vivo experiments were carried out at least three
times. Quantitative RT-PCR data are presented as mean
± SEM. The data sets were analyzed using paired-sample
Wilcoxon signed-rank test in GraphPad Prism 5 (GraphPad
Software, Inc., La Jolla, CA, USA). P values < 0.05 were
considered statistically significant.
Mucus staining in tracheal whole mounts
Tracheae were incubated in 1 ml HEPES-Ringer solution
at 30 °C; 1 μl of a 1:1 mix of wheat germ agglutinin
(WGA) and Ulex europaeus agglutinin (UEA-1) was
added (each 1 μg/ml). WGA stains N-acetyl-D-glucosa-
mine and sialic acid residues, whereas UEA-1 has an
affinity for L-fucose, all of which are carbohydrate
residues present in mucins [48, 49]. In addition, WGA
labels ciliated cells [50]. The staining was imaged with
an AxioMR camera and an Achroplan 40×/0.8 W objective
with a resolution of 1388 × 1040 pixels.
Further information on the determination of cytokine
levels and cell viability in vitro, CBNP aerosol generation
and exposure of rats, oxidative Comet-Assay, histopath-
ology of the rat lungs, particle suspensions in cell culture
medium, preparation and culture conditions of intrapul-
monary airways, qualitative RT-PCR, macroscopic analysis,
scanning electron microscopy and individual statistics are
provided in Additional file 5.
Results
Characterization of CBNP and their suspensions
All of the tested nanoparticles had similar hydro-
dynamic diameters and ζ-potentials in medium
(Table 1 and Additional file 1). P90 without PAHs
had a mean primary particle size of 16.5 nm (Table 1
and Additional file 1). The minimal mass loss at the
final temperature of 800 °C indicated that P90 had
negligible volatile compounds on the surface. The
coating of P90 nanoparticles with BaP or 9NA re-
duced the specific surface area about one third.
P90-BaP and P90-9NA had almost the same mass loss,
indicating a similar PAH proportion on the CBNP surface
(Table 1 and Additional file 2A).
AS-PAH exhibited a slightly larger specific surface area
and mass loss compared with the coated P90 nano-
particles, and AS-PAH without PAHs showed a slightly
smaller mean primary particle size than uncoated P90
(Table 1 and Additional file 1).
The thermogravimetric (TG) analysis of AS-PAH
indicated a two-stage thermal desorption of surface
components (Additional file 2B). The first stage ended at
approximately 240 °C and mainly included PAHs
(Additional file 2C). Because of possible defragmenta-
tion, the exact PAH content cannot be determined, but a
minimal PAH content of approximately 11% was
calculated via TG curve correlating with the mass loss at
240 °C (Additional file 2C). In the second stage, hydro-
gen, methane, water, acetylene and carbon dioxide were
mainly released (Additional file 2D).
With combined TG/MS analysis, we detected PAHs
with a maximal mass-to-charge ratio of 202 (Additional
file 2E). Due to the possible condensation of high weight
PAHs with a boiling point with more than 400 °C before
MS inlet, we extracted the PAHs from AS-PAH and
Table 1 Characteristics of dry and suspended CBNP
Particle properties P90 P90-BaP P90-9NA AS-PAH
Mean primary particle size (nm) 16.5 ± 0.4a 16.5 ± 0.4a 16.5 ± 0.4a 14.2 ± 0.1a
Mass loss (%) 0.5 ± 0.4 16.1 ± 0.5 14.6 ± 0.1 19.0 ± 0.7
Specific surface area (m2/g) 302 ± 16 91 ± 2 91# 115 ± 3
Hydrodynamic diameter in water/BSA (nm) 155 ± 1 176 ± 5 172 ± 7 174 ± 5
ζ-potential in water/BSA (mV) −34 ± 5 −38 ± 4 −37 ± 3 −36 ± 3
Hydrodynamic diameter in medium (nm) 163 ± 6 160 ± 8 156 ± 11 170 ± 4
ζ-potential in medium (mV) −15 ± 1 −13 ± 1 −13 ± 1 −12 ± 1
Data are mean ± SEM. ameasurement without PAHs; n = 3–13, except #n = 1
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analyzed them with gas chromatographic (GC)/MS. The
results are reported in Table 2 and Additional file 2 F.
Endotoxins were not detected in any CBNP test
preparation.
Analysis of CBNP effects in vitro
The in vitro effects of CBNP depended on the cell line
A549 cells are widely accepted as a general model for
lung epithelium. ROS formation was increased in these
cells by P90 and AS-PAH, but not by P90-BaP or P90-
9NA (Table 3). The highest ROS levels were detected
after treatment with AS-PAH at both dose levels
(Table 3), although P90 was the only particle that in-
duced mRNA expression of IL-8 (Table 3).
16HBE14o- cells are regarded as model for bronchial
epithelial cells. In these cells, all CBNP induced ROS for-
mation at 50 μg/ml, but only P90-9NA increased IL-8
mRNA expression. Calu-3 cells are models for both
bronchial epithelial cells and epithelial barrier function.
In these cells, P90-BaP and AS-PAH induced IL-8
mRNA expression; only AS-PAH reduced TEER
(Table 3). AS-PAH-induced IL-8 protein release was sig-
nificantly increased compared to that following P90 ex-
posure (Additional file 6A). IL-6 protein was significantly
increased in the supernatant after exposure to 50 μg/ml
P90-BaP, and following exposure to both concentrations
of AS-PAH (Additional file 6B). Cell viability was not
significantly affected by the tested CBNP at either concen-
tration (Additional file 6C).
In vivo nose-only inhalation study in rats
CBNP aerosol characterization
Aerosol concentrations and mass median aerodynamic
diameters (MMADs) are summarized in Additional file 7.
The mean concentrations were close to the target concen-
tration (6 mg/m3) for all aerosols, and all MMADs were
below 3 μm.
Only AS-PAH increased the relative lung weights and
induced a moderate inflammatory response
On day 1 after cessation of exposure, relative lung weights
were significantly increased only in the AS-PAH group
(Fig. 1), with absolute lung wet weights increased in both
the AS-PAH and P90-BaP inhalation group (Additional
file 8). After a 14 day recovery period, the only effect seen
in the inhalation groups was a slight decrease in the
terminal body weight in the AS-PAH group (Fig. 1).
On day 1 post-exposure, there was a statistically signifi-
cant increase in polymorphonuclear granulocyte numbers
in the animals exposed to P90 and AS-PAH compared to
the clean air control group (Fig. 1). In AS-PAH treated an-
imals, numbers of polymorphonuclear granulocytes were
still moderately increased on day 14 compared to clean air
treated animals, indicating the presence of a mild chronic
Table 2 Identified PAHs extracted from the AS-PAH surface
Peak m/z Retention
time (min)
Name Sum formula Rings IARC carcinogens
classification
Identified by
1 128 10.867 Naphthalene C10H8 2 2B M
2 152 14.250 Biphenylene C12H8 3 – NIST
3 152 14.900 Acenaphthylene C12H8 3 – M
4 166 16.583 Fluorene C13H10 3 3 M
5 178 18.867 Phenanthrene C14H10 3 3 NIST
6 178 18.958 Anthracene C14H10 3 3 M
7 190 20.308 Benzo[def]fluorene C15H10 4 – NIST
8 202 21.725 Fluoranthene C16H10 3 3 M
9 202 22.233 Pyrene C16H10 4 3 M
10–12 226 24.667–25.125 Cyclopenta[cd]pyrene/
Benzo[ghi]fluoranthene
C18H10 5 2A 3 NIST
13 240 26.450 9H-Cyclopenta[a]pyrene C19H12 5 – NIST
14 252 28.225 Benzo[j]fluoranthene C20H12 5 2B NIST
15 276 30.775 Benzo[ghi]perylene C20H12 6 3 NIST
16 276 30.992 Indeno[1,2,3-cd]pyrene C20H12 6 2B NIST
17 300 33.150 Coronene C24H12 7 3 NIST
PAH compounds were analyzed with GC/MS and identified by reference substances (M) or by the National Institute of Standards and Technology Database (NIST).
Some of the compounds are represented as isomers. A representative GC/MS chromatogram of PAHs from an AS-PAH sample is shown in Additional file 2 F. PAHs
are classified by International Agency for Research on Cancer (IARC) monographs: 2A means “probably carcinogenic to humans”; 2B means “possibly carcinogenic
to humans” and 3 means “not classifiable as to its carcinogenicity to humans” [90]. m/z =mass-to-charge ratio
Lindner et al. Particle and Fibre Toxicology  (2017) 14:8 Page 8 of 17
inflammatory response (Fig. 1). None of the tested CBNP
influenced LDH, β-glucuronidase activity, or total protein
levels in BAL fluid (Additional file 9A), and none induced
oxidative DNA damage in BAL cells (Additional file 9B).
CBNP exposure induced very slight histological alter-
ations (Additional file 10). However, only AS-PAH induced
bronchiolo-alveolar hyperplasia, observed in two of five ani-
mals on day 14 post-exposure (Additional file 10).
Ex vivo airway models
As the in vivo experiments did not specifically address
airway epithelial function but in vitro experiments indi-
cated that airway epithelial cells are sensitive to CBNP
effects, we examined the particle effects on explanted
murine airways.
Only AS-PAH caused a pro-inflammatory response in the
tracheal epithelium
Compared to medium controls, only AS-PAH significantly
increased the mRNA expression of pro-inflammatory IL-6
(30 μg/ml), and of keratinocyte chemoattractant (KC), the
murine homologue of human IL-8) (Table 4). In con-
trast, P90-BaP and P90-9NA decreased IL-6 mRNA
expression at 30 μg/ml (Table 4). No increase of KC
or IL-6 mRNA was detected in the intrapulmonary
airways, indicating that the effects observed are region
specific (Additional file 11).
Table 3 In vitro results of ROS, IL-8 mRNA expression and TEER measurement after exposure to CBNP
A549 cells 16HBE14o- cells Calu-3 cells
Relative DCF fluorescence IL-8 Relative DCF fluorescence IL-8 TEER (%) IL-8
P90 10 μg/ml 1.2 ± 0.2 1.2 ± 0.4 1.5 ± 0.2** 1.4 ± 0.2 103 ± 7 1.0 ± 0.2
50 μg/ml 2.1 ± 0.5* 2.1 ± 0.8** 3.2 ± 1.1** 1.7 ± 0.9 109 ± 8 1.1 ± 0.0
P90-BaP 10 μg/ml 1.1 ± 0.1 0.7 ± 0.2 1.3 ± 0.1 0.7 ± 0.3 97 ± 8 1.9 ± 0.6**
50 μg/ml 1.2 ± 0.1 0.7 ± 0.2 2.1 ± 0.1** 1.9 ± 1.8 94 ± 9 3.0 ± 0.9**
P90-9NA 10 μg/ml 0.9 ± 0.1 0.8 ± 0.2 1.1 ± 0.1 1.1 ± 0.5 105 ± 10 1.1 ± 0.1
50 μg/ml 1.2 ± 0.2 0.8 ± 0.2 2.1 ± 0.3** 2.0 ± 0.9* 104 ± 9 1.2 ± 0.1
AS-PAH 10 μg/ml 2.3 ± 0.2** 0.8 ± 0.3 1.8 ± 0.2** 1.1 ± 0.4 91 ± 7* 1.1 ± 0.2
50 μg/ml 3.0 ± 0.4** 0.8 ± 0.3 1.9 ± 0.1** 1.4 ± 0.8 90 ± 6* 2.1 ± 1.2**
Data show the n-fold change compared to medium controls of relative DCF fluorescence in A549 and 16HBE14o- cells, the n-fold change of relative IL-8 mRNA
expression in A549, 16HBE14o- and Calu-3 cells, respectively, and the changes of TEER in Calu-3 cells after 24 h CBNP exposure
Data are mean ± SD. n = 3–5, *p < 0.05 and **p < 0.01 CBNP compared to medium controls analyzed by two-sided Student’s t-test for unpaired values (ROS analysis
and TEER results) or Mann Whitney U test (mRNA expression data)
Fig. 1 P90 and AS-PAH induced an inflammatory response in vivo. The diagrams show relative lung weights (a), the amount of total cells (b) and
results of differential cell counts in BAL fluid (c-e) after nose-only inhalation. Data are mean ± SD; n= 10 results of relative lung weight; n= 5 for total cell
count and differential cell counts; *p< 0.05 and **p< 0.01 CBNP exposure compared to clean air control, analyzed by analysis of variance and Dunnett’s
test; PMNs = polymorphonuclear cells, D1 = day 1 post-exposure, D14 = day 14 post-exposure
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All PAH containing CBNP induced Cyp-expression but none
of the CBNP induced mRNA for indicators of oxidative
stress in tracheal epithelial cells
We analyzed the mRNA expression of the cytochrome
P450 enzymes Cyp1A1 and Cyp1B1 as indicators of
PAH metabolism, and of Gpx3 and Gr as indicators of
oxidative stress.
All PAH-containing CBNP induced Cyp1a1 and
Cyp1b1 mRNA in the tracheal epithelium (Table 4).
The most potent CBNP was AS-PAH, followed by
P90-BaP. P90-9NA only induced Cyp1a1 and Cyp1b1
mRNA expression at 30 μg/ml. In contrast, the un-
coated P90 nanoparticles did not induce Cyp1a1
mRNA expression, and significantly decreased Cyp1b1
mRNA expression compared to medium controls in
tracheal epithelial cells (Table 4). None of the CBNP
increased the mRNA expression of Gpx3 or Gr. In
intrapulmonary airways PAH-containing CBNP in-
duced a similar expression pattern of Cyp1a1 mRNA
compared to the tracheal epithelium; no increase of
mRNAs for anti-oxidative enzymes was detected
(Additional file 11).
Since the mRNA data of Cyp-expression indicated that
the CBNP affect airway epithelial cells and to detect
changes in epithelial function, we assessed their impact
on cilia-driven transport.
Only P90 forms microscopically visible agglomerates;
these bind to mucus and interact with ciliated cells
On microscopic examination of tracheae, visible agglom-
erates were observed on the airway epithelium after 24 h
of incubation with P90 at 10 μg/ml and 30 μg/ml
(Additional file 12A). These agglomerates were bound ei-
ther to mucus on the epithelium or directly to cilia of cili-
ated cells (Fig. 2a and b and Additional files 13 and 14).
None of the PAH-containing CBNP showed microscopic-
ally visible agglomerates at either tested concentration
(Additional file 12A).
At 10 μg/ml, P90 agglomerates increased ciliary beat
frequency but mucus reduced particle transport speed
Compared to medium control, P90 at 10 μg/ml in-
creased mean ciliary beat frequency (Fig. 2c), although it
did not increase the mean of cilia-driven particle trans-
port speed (Fig. 2d). Cells with bound agglomerates ex-
hibited a higher ciliary beat frequency compared to cells
without visible agglomerates (Additional file 12B and C).
Furthermore, particle transport speed was reduced in
areas with mucus and increased in areas without mucus
compared to medium control (Additional file 12D). In-
cubation with P90 at a concentration of 1 μg/ml did not
result in formation of agglomerates, and therefore did
not increase ciliary beat frequency (Additional files 12A
and 15A). However, this concentration was sufficient to
increase mucus (Additional files 15B and C), and conse-
quently to reduce particle transport speed (Additional
file 15D).
At 10 μg/ml, PAH-coated P90 did not increase ciliary beat
frequency but differently influenced mucus release and
particle transport speed
As expected from the inability to form agglomerates,
neither P90-BaP nor P90-9NA increased ciliary beat fre-
quency (Fig. 2e and f). Incubation with P90-BaP in-
creased amounts of mucus on the epithelial cells
(Additional files 16 and 17), with a consequent reduced
particle transport speed compared to control (Fig. 2g
and h). In contrast to P90 at 10 μg/ml, we observed dead
cells on the epithelium during the experiments with
both coated particles (Additional files 16, 17 and 18).
At 10 μg/ml, AS-PAH increased ciliary beat frequency and
mucus release but reduced particle transport speed
Although AS-PAH did not form agglomerates, it in-
creased ciliary beat frequency and resulted in mucus re-
lease (Fig. 2i, and Additional files 12A and 19). Compared
to control, AS-PAH reduced particle transport speed
Table 4 Results of mRNA expression in tracheal epithelial cells after CBNP exposure
P90 P90-BaP P90-9NA AS-PAH
10 μg/ml 30 μg/ml 10 μg/ml 30 μg/ml 10 μg/ml 30 μg/ml 10 μg/ml 30 μg/ml
KC 1.1 ± 0.2 1.1 ± 0.2 1.2 ± 0.2 0.7 ± 0.2 1.3 ± 0.2 1.2 ± 0.3 3.8 ± 1.5* 2.4 ± 0.6*
IL-6 0.7 ± 0.2 0.8 ± 0.1 1.0 ± 0.2 0.6 ± 0.1* 1.3 ± 0.3 0.7 ± 0.1* 2.0 ± 0.8 2.6 ± 0.4*
Gpx3 2.2 ± 0.9 0.7 ± 0.1* 0.8 ± 0.2 0.8 ± 0.1 1.7 ± 0.7 0.7 ± 0.1 5.2 ± 3.8 1.3 ± 0.5
Gr 0.7 ± 0.1* 0.7 ± 0.1* 1.0 ± 0.1 1.0 ± 0.1 1.4 ± 0.2 1.0 ± 0.2 1.5 ± 0.3 1.7 ± 0.5
Cyp1a1 1.4 ± 0.4 0.8 ± 0.3 331 ± 22* 1289 ± 412* 2.0 ± 1.0 30 ± 9* 1157 ± 232* 2442 ± 452*
Cyp1b1 0.2 ± 0.1* 0.2 ± 0.0* 5.3 ± 1.0* 10.9 ± 2.4* 1.3 ± 0.1 2.5 ± 0.6* 11.1 ± 4.3* 4.3 ± 0.7*
Data show the n-fold mRNA expression after CBNP exposure compared to medium controls. Exposure time was 24 h. Data are mean ± SEM. n = 5–7, *p < 0.05
CBNP compared to medium controls analyzed by Wilcoxon signed-rank test
Gpx3 Glutathione peroxidase 3, Gr Glutathione reductase, KC keratinocyte chemoattractant, IL-6 interleukine-6, Cyp1a1/Cyp1b1 Cytochrome P450 subtypes 1a1
and 1b1
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(Fig. 2j), and, as with both coated particles, we observed
dead cells on the epithelium (Additional file 19).
At 30 μg/ml, all particles resulted in reduced particle
transport speed
At 30 μg/ml, none of the particles increased ciliary beat
frequency but all reduced particle transport speed
(Fig. 2k to n and Additional file 20). All particles
increased mucus, and dead cells were visible on the
epithelium (Additional files 16, 17, 18 and 19).
PAH-containing particles induced apoptosis in tracheal
epithelial cells
At 10 μg/ml, P90 did not increase cell death (Fig. 3a and
b). In contrast, at this concentration all PAH-containing
particles increased cell death, with inducing apoptosis
(Fig. 3a) and P90-9NA and AS-PAH also increasing the
number of necrotic cells (Fig. 3b). At 30 μg/ml, all parti-
cles increased cell death, with the PAH-coated particles
inducing both necrosis and apoptosis, whereas P90 only
increased necrosis (Fig. 3a and b). Of note, necrotic and
Fig. 2 PAH altered P90 induced effects on mucociliary clearance in the ex vivo murine trachea. a Mucus on the epithelium was stained with a
mixture of wheat germ agglutinin (WGA) and Ulex europaeus agglutinin-1 (UEA-1) after exposure to P90. White arrows indicate mucus structures
associated with P90 agglomerates. b P90 agglomerates attached to cilia of ciliated epithelial cells. Red arrows indicate P90 agglomerates. c, d Ciliary
beat frequency (c) and particle transport speed (d) after exposure to 10 μg/ml P90. e-h Ciliary beat frequency (e, f) and particle transport speed (g, h)
after exposure to 10 μg/ml P90-BaP or P90-9NA. i, j Ciliary beat frequency (i) and particle transport speed (j) after exposure to 10 μg/ml AS-PAH. k-n
Particle transport speed after exposure to 30 μg/ml P90 (k), P90-BaP (l), P90-9NA (m) and AS-PAH (n). c, e, f, i Each point represents the mean ciliary
beat frequency of at least 50 ciliated cells measured at eight different tracheal regions of each animal. d, g, h, k-n Each point represents the mean
particle transport speed of added polystyrene particles measured at eight different tracheal regions of each mouse. A minimum of n = 5 animals were
analyzed. The exposure time was 24 h for all experiments. p < 0.05 was considered statistically significant. The medium controls were compared to
CBNP exposure analyzed by Wilcoxon signed-rank test
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apoptotic cells represented no more than 2% of all
counted airway epithelial cells, suggesting that this small
amount of damage might not be detectable with com-
mon assays.
Discussion
Our results suggest that the biological effect of PAH-
coating is a combination of specific surface area and
PAH-specific effects.
In our study, we used four CBNP: P90, P90 coated
with BaP (P90-BaP), P90 coated with 9NA (P90-9NA),
and, to model nanoparticles that acquire PAH during
synthesis, a soot derived from acetylene combustion that
contains various PAHs (AS-PAH). This allowed us to
examine how PAH coating changes the behavior of the
P90 nanoparticle in various test systems. These particles
were tested in vitro, ex vivo and in vivo.
Particle characteristics
Nanoparticle reactivity is determined by the surface re-
activity, including the nanoparticle characteristics: size,
shape, solubility, surface area, and chemical composition
[2, 5, 8, 9, 51, 52]. All particles that we used had similar
primary particle size, shape, and hydrodynamic diame-
ters and ζ-potential in medium. An equal solubility was
accomplished by adding protein, resulting in negative
ζ-potential at physiological pH-value. Thus, any differ-
ences observed are attributable to the surface area or
surface chemical composition of the CBNP. Coating of
P90 with either PAH reduced its surface area from
302 m2/g to 91 m2/g; since the effects of P90 in bio-
logical systems are attributed to its high surface area,
this reduction would be expected to reduce the observed
biological effects [1, 10].
BaP is considered a tumorigenic reference PAH, with
well characterized effects, including induction of ROS
formation, IL-8 release and apoptosis [6, 15, 53–57]. It is
metabolized by Cyp1A1 and 1B1, and has been shown
to upregulate these enzymes both on mRNA and protein
levels [23, 58]. Thus, increases in Cyp1a1 and 1b1
mRNA indicate that this PAH is bioavailable in cells.
PAH with 4 and more aromatic rings and specific struc-
tural features (Bay- or Fjord-region) are strong Cyp in-
ducers and considered to be tumorigenic [15, 59]. Since
9NA is composed of only three aromatic rings, it is less
toxic than BaP and considered as weak Cyp inducer
[15, 43] as confirmed by our Cyp1a1 and Cyp1b1
mRNA expression results.
Since it is possible that coating of CBNP may result in
a different distribution of PAH compared to particles
that acquire PAH during synthesis, we also used AS-
PAH synthesized from acetylene combustion as a test
compound [44, 60]. Since AS-PAH has a similar surface
area, shape, size and solubility compared to PAH-coated
P90, the different effects of these particles observed in
the biological systems are likely the result of its different
PAH composition [61, 62]. The AS-PAH that we synthe-
sized contained a mixture of at least 17 PAH with 2–7
aromatic rings that could be removed from the particle
with organic solvents, indicating that these PAH are on
the surface of the particle. Several of the identified PAH
are predicted to be metabolized by Cyp1A1 and 1B1 and
induce their mRNA. Thus, by determining the mRNA
expression of both enzymes allowed us to determine if
the PAHs from AS-PAH are bioavailable. The presence
of PAHs with 5 or more aromatic rings predict that,
compared to BaP, the PAH mixture of AS-PAH would
be more toxic [15, 63]. For example, compared with BaP
the 5-ring component cyclopenta[cd]pyrene induced the
same mutation mechanism [64], a stronger lung tumori-
genic response in A/J mice [65] and was 6.9 ± 4.2-fold
more mutagenic in vitro [43]. In addition, PAH-mixtures
are often more toxic than would be expected by simple
addition of the individual PAH toxicities [65, 66]. Thus,
when not bound to CBNP the PAH mixture from
AS-PAH is likely to be more toxic compared to BaP.
Since the relative in vivo effects of PAHs depend on
their bioavailability, their clinical impact cannot be fully
Fig. 3 Surface PAHs increased epithelial toxicity of CBNP in the ex vivo murine tracheal model. The diagrams show the quantification of apoptotic
(a) and necrotic (b) epithelial cell numbers. Data represent the total number of necrotic and apoptotic cells counted in whole mount preparation after
24 h exposure to CBNP compared to medium controls. All data are mean ± SEM. n= 5–11, *p< 0.05 and **p< 0.01, CBNP compared to medium controls
analyzed by Wilcoxon signed-rank test
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predicted without appropriately designed and conducted
studies, such as those we report here.
When predicting the behavior of PAH-coated versus
uncoated nanoparticles in biological systems, three dif-
ferent scenarios are possible. First, the reduction of the
surface area could reduce the biological effects of CBNP,
and differences in the PAHs would therefore not have an
impact. Second, the PAH content could increase the bio-
logical effects of CBNP due to the toxicity of PAH – and
so irrespective of the particle’s surface area. A third pos-
sibility is that toxicity could be decreased in some cell
types due to the reduced surface area, but increased in
other cell types due to PAH toxicity.
Biological effects of uncoated and PAH-coated CBNP
Supporting the hypothesis that a reduced surface area
reduces the biological effects of CBNP [1, 10, 67], the
coating of P90 with BaP prevented the P90-induced in-
crease of the neutrophil attracting cytokine IL8 mRNA
in A549 cells. As the high surface area of P90 is strongly
associated with induction of oxidative stress, the reduced
biological effect can be explained by the reduced ROS
release that we observed with P90-BaP and P90-9NA in
A549 cells compared to uncoated P90. This reduced
biological effect is also supported by our observation
that P90, and not P90-BaP, led to a transient increase in
granulocyte influx in the in vivo experiment. This transi-
ent increase in granulocytes without changes of total cell
number has previously been observed [68, 69]. The
mechanism for the reduced number of macrophages is
not known and would be an interesting area for future
research. However, these results clearly demonstrate that
surface area can be an important factor of CBNP effects
in biological systems.
However, other results support the theory that PAH
can increase the effects of CBNP [29]. Firstly, we found
that P90-BaP, P90-9NA and AS-PAH induced apoptosis
in tracheal epithelial cells ex vivo, whereas P90 did not.
This is consistent with previous reports describing apop-
tosis induction by PAH [54, 56, 57, 70]. Secondly, PAH-
coated P90 and AS-PAH strongly induced Cyp mRNA
expression. Cyp1a1 and Cyp1b1 mRNA are known to be
induced by PAH in a subgroup of airway epithelial cells
[71], and so their induction in both the trachea and
intrapulmonary airways demonstrate that the PAH are
biologically active. Interestingly, the assumed differences
between P90-9NA, P90-BaP and AS-PAH are also
reflected in the level of induction of Cyp1a1 and Cyp1b1
mRNA, in that P90-9NA resulted in the least induction,
followed by P90-BaP, with the strongest induction by
AS-PAH. Finally, AS-PAH was the only CBNP to reduce
TEER in vitro, to increase BAL granulocyte content
14 days after the last application, and induce both
histological changes in vivo and inflammatory mediator
mRNA expression (KC and IL-6) ex vivo. Furthermore,
AS-PAH had the highest apoptosis rate in tracheal
epithelium ex vivo.
Our data therefore suggest that the overall biological
impact of a PAH depends on the relative contribution of
surface area reduction and PAH-induced toxicity, that is,
in turn, influenced by the biological system. This is ex-
emplified by cilia-driven particle transport speed, which
is influenced by ciliary beat frequency, mucus release
and epithelial cell death.
In the ex vivo trachea, P90 was the only particle to
form aggregates. These aggregates bound to ciliated cells
and increased ciliary beat frequency. Furthermore,
microscopically visible nanoparticle agglomerates have
been shown to increase ciliary beat frequency in the
murine trachea [72]. A similar effect has been observed
in the bovine trachea where polystyrene particles
>200 nm in diameter that attach to cilia increase ciliary
beat frequency due to mechanical stimulation of axo-
nema possibly involving second messengers such as
cAMP or cGMP [73], both of which are known to in-
crease ciliary beat frequency [74]. In addition, mechan-
ical stimulation of cilia triggers Ca2+ influx, with a
consequent increase in ciliary beat frequency [75]. Coat-
ing of P90 with PAHs prevented aggregate formation
and consequently neither P90-BaP nor P90-9NA impact
ciliary beat frequency. Thus, this shows that PAH coat-
ing of P90 reduced its effects on a biological system by
changing its surface properties and not by a specific
PAH toxicity. However, we detected an increase in epi-
thelial cell apoptosis after application of P90-BaP and
P90-9NA compared to P90. This increase in apoptosis
together with the induction of Cyp enzymes can directly
be ascribed to PAH toxicity [70].
AS-PAH increased ciliary beat frequency without
forming microscopically visible agglomerates. Interest-
ingly, fluoranthene, a PAH that we detected on the sur-
face of AS-PAH, has previously been shown to induce a
persistent increase in Ca2+ in Calu-3 cells, whereas BaP
and anthracene did not [76]. Since an increase in intra-
cellular Ca2+ is known to increase ciliary beat frequency
[74], it is possible that fluoranthene is directly respon-
sible for the increased ciliary beat frequency. Despite
increasing ciliary beat frequency there was a marked
reduction in particle transport speed, possibly due to
increased apoptosis and mucus release.
Previous research has shown that despite being bound
to the surface of CBNP, PAHs can be bioavailable [77].
Our data confirm that PAH bound to CBNP exerts
biological effects in epithelial cells, as demonstrated by
Cyp1a1 mRNA induction. Cyp1a1 mRNA expression is
a very sensitive parameter for detecting biologically
active PAHs [78]. The induction of Cyp1a1 mRNA is
triggered by binding of PAH to the aryl hydrocarbon
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receptor (AhR) that then translocates into the cell nu-
cleus, and interacts with AhR nuclear translocator [79].
This complex then induces Cyp1a1 mRNA expression
by binding to xenobiotic response elements [79]. In low
concentrations, AhR activation suppresses the activity of
the transcription factor p65 [80], which is known to in-
duce the mRNA expression of IL-6 and IL-8 [81, 82].
We also observed a small but significant decrease in
IL-6 mRNA expression in the epithelium of explanted
tracheae, possibly due to AhR activation. At higher con-
centrations, PAHs can lead to IL-6 and IL-8 mRNA
expression [80] – as we observed with AS-PAH. In gen-
eral, AS-PAH had more effects than the PAH-coated
CBNP, probably due to the composition of PAH present
on the particle’s surface. As discussed above, the PAH
fluoranthene induces prolonged increase in intracellular
Ca2+ in Calu-3, whereas BaP and anthracene do not
[76]. Yamaguchi et al. also observed an increase of intra-
cellular Ca2+ that was independent from AhR [83], indi-
cating that PAH have additional activities apart from the
classical AhR pathway. Identification of the specific PAH
and/or PAH mixture that is responsible for the increased
effects of AS-PAH would require additional research,
although fluoranthene and compounds such as cyclo-
penta[cd]pyrene are possible candidates.
We have shown that AS-PAH exerts more toxic effects
than P90 despite its reduced surface area. We attribute
this to the composition of the surface PAHs. The relative
toxicity of P90-9NA and P90-BaP, and the resultant bio-
logical effect, depended on the test system used.
Choice of test systems
In general, cell lines can give valuable information if the
test substance is interfering with basal cell functions
present in all cells. However, if cell lines lack specific
pathways that are important for toxic effects, their value
for predicting in vivo toxicity is limited [84].
The prediction of an in vivo effect based on results ob-
tained in a single cell line is made more challenging,
since both changes in surface area and direct PAH
toxicity impact the overall effect of particles. This may
explain why we had different results in terms of IL-8
mRNA production in different cell lines. The reason for
these differences was most likely that some cell lines
were more sensitive to the toxic effects of the PAHs,
whereas others were more sensitive to changes in sur-
face area. An in vivo experiment in which all target cell
types are present is therefore in principle better suited
to detect effects [84]. However, in a single in vivo experi-
ment, only a limited number of parameters can be deter-
mined. The readouts predetermined in the OECD
experiment focus on inflammation and cell death. They
do not address effects on mucociliary clearance. It
should be noted, however that sustained impairment of
mucociliary clearance can have substantial health effects
[85–88] that are missed in animal models by focusing
solely on inflammation and cell death. In principle, in
vivo experiments can be designed to also include these
parameters. However, this would be time consuming and
cost intensive. The strength of short-term organ culture
models is that they can be adapted to screen for specific
organ functions that are not routinely examined in stan-
dardized in vivo experiments. This was demonstrated by
using our ex vivo trachea model that allowed examining
the complex interplay between mucus production, ciliary
beating and cell death [72, 89].
Conclusions
Using a range of different test systems our results dem-
onstrate that the biological effect of CBNP is determined
by a combination of specific surface area and the com-
position of the surface-bound PAH, and varies in differ-
ent target cells. Specifically, AS-PAH exerted more toxic
effects than P90 despite its reduced surface area. We at-
tribute this to the composition of the surface PAHs.
However, the relative toxicity of P90-9NA and P90-BaP
depended on the test system used.
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